Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine

Arzneimittel-Forschung/Drug Research

Volumn 60, Issue 7, 2010, Pages 421-426

  Keränen, Tapani ^a,b   Sorri, Annamari ^b   Moilanen, Eeva ^b,c   Ylitalo, Pauli ^b,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antiepileptic drugs; CAS 28721 07 5; CAS 84057 84 1; Lamotrigine, overdose, pharmacokinetics; Oral activated charcoal; Oxcarbazepine, overdose, pharmacokinetics

Indexed keywords

ACTIVATED CARBON; DRUG METABOLITE; LAMOTRIGINE; LICARBAZEPINE; OXCARBAZEPINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHARCOAL; TRIAZINE DERIVATIVE;

ADULT; ARTICLE; DRUG ABSORPTION; DRUG ELIMINATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; ANALOGS AND DERIVATIVES; AREA UNDER THE CURVE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECTS; HALF LIFE TIME; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; ANTICONVULSANTS; AREA UNDER CURVE; CARBAMAZEPINE; CHARCOAL; CROSS-OVER STUDIES; FEMALE; HALF-LIFE; HUMANS; INTESTINAL ABSORPTION; MALE; TRIAZINES; YOUNG ADULT;

EID: 77955384907     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296306     Document Type: Article

References (26)

1. Ettinger AB, Argoff CE. Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain. Neurotherapeutics. 2007;4:75-83.
2. Cohen AF, Land GS, Breimer DD, Yuen WC, Winton C, Peck AW. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin Pharmacol Ther. 1987;42:535-41. (Pubitemid 18002171)
3. Bourgeois BFD: Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed. Neurology. 2000;55 Suppl 3:S11-6.
4. Chan V, Morris RG, Ilett KF, Tett SE. Population pharmacokinetics of lamotrigine. Ther Drug Monit. 2001;23:630-5.
5. Dickinson RG, Hooper WD, Dunstan PR, Eadie MJ. First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metabolite. Eur J Clin Pharmacol. 1989;37:69-74.
6. May TW, Korn-Merker E, Rambeck B. Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet. 2003;42:1023-42.
7. Kristensen O, Klitgaard NA, Jonsson B, Sindrup S. Pharmacokinetics of 10-OH-carbazepine, the mean metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations. Acta Neurol Scand. 1983;68:145-50. (Pubitemid 13023008)
8. Lloyd P, Flesch G, Dieterle W. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia. 1994;35 Suppl 3:S10-3.
9. Sbei M, Campellone JV. Stupor from lamotrigine toxicity. Epilepsia. 2001;42:1082-3.
10. Lofton AL, Klein-Schwartz W. Evaluation of lamotrigine toxicity reported to poison centers. Ann Pharmacother. 2004;38:1811-5. (Pubitemid 39425713)
11. Dinnerstein E, Jobts BC, Williamson PD. Lamotrigine intoxication provoking status epilepticus in an adult with localization-related epilepsy. Arch Neurol. 2007;64:1344-6. (Pubitemid 47403093)
12. Reimers A, Reinholt G. Acute lamotrigine overdose in an adolelescent. Ther Drug Monit. 2007;29:669-70.
13. Van Opstal JM, Janknegt R, Cilissen J, L'Ortije WH, Nel WH, De Heer F. Severe overdosage with the antiepileptic drug oxcarbazepine. Br J Clin Pharmacol. 2004;58:329-31. (Pubitemid 39209067)
14. Furlanut M, Franceschi L, Poz D, Silvestri L, Pecorari M. Acute oxcarbazepine, benazepril, and hydrochlorothiazide overdose with alcohol. Ther Drug Monit. 2006;28:267-8. (Pubitemid 44314960)
15. Neuvonen PJ. Clinical pharmacokinetics of oral activated charcoal in acute intoxications. Clin Pharmacokinet. 1982;7:465-89.
16. Neuvonen PJ, Olkkola KT. Oral activated charcoal in the treatment of intoxications: role of single and repeated doses. Med Toxicol Adverse Drug Exp. 1988;3:33-58.
17. Montoya-Cabrera MA, Sauceda-Garcia JM, Escalante-Galindo P, Flores-Alvarez E, Ruiz-Gomez A. Carbamazepine poisoning in adolescent suicide attempters: effectiveness of multiple-dose activated charcoal in enhancing carbamazepine elimination. Arch Med Res. 1996;27:485-9. (Pubitemid 26411589)
18. Brahmi N, Kouraichi N, Thabet H, Amamou M. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. Am J Emerg Med. 2006;24:440-3. (Pubitemid 43903595)
19. Hiller A, Nguyen N, Strassburg CP, Li Q, Jainta H, Pechstein B, et al. Retigabine N-glucuronidation and its potential role in the enterohepatic circulation. Drug Metab Dispos. 1999;27:605-12. (Pubitemid 29214473)
20. Menge GP, Dubois JP, Bauer G. Simultaneous determination of carbamazepine, oxcarbazepine and their main metabolites in plasma by liquid chromatography. J Chromatogr. 1987;414:477-83. (Pubitemid 17041703)
21. Fraser AD, MacNeil W, Isner AF, Camfield PR. Lamotrigine analysis in serum by high-performance liquid chromatography. Ther Drug Monit. 1995;17:174-8.
22. Briassoulis G, Kalabalikis P, Tamiolaki M, Hatzis T. Lamotrigine childhood overdose. Pediatr Neurol. 1998;19:239-42.
23. Barker MJ, Benitez JG, Ternullo S, Juhi GA. Acute oxcarbazepine and atomoxetine overdose with quetiapine. Vet HumToxicol. 2004;46:130-2. (Pubitemid 38650083)
24. Zidd AG, Hack JB. Pediatric ingestion of lamotrigine. Pediatr Neurol. 2004;31:71-2.
25. Olkkola KT, Neuvonen PJ. Treatment of intoxications using single and repeated doses of oral activated charcoal. J Toxicol Clin Exp. 1989;9:265-75.
26. Alaspää AO, Kuisma MJ, Hoppu K, Neuvonen PJ. Out-of-hospital administration of activated charcoal by emergency medical services. Ann Emerg Med. 2005;45:207-12.